Physician

Rahul Kumar Vangala, M.D.

According to 2025 Medicare claims, Rahul Vangala, M.D. (NPI: 1366499246) practices allergy/immunology in the Warner Robins, GA market, with the plurality of this provider's patient population coming from Houston, GA. This provider's primary affiliated billing organization is ALLERGY & ASTHMA CENTER OF MIDDLE GEORGIA, INC. (NPI: 1831352574; TIN: 88-0869371) and primary practice location at 31210-1825. Vangala is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Vangala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 152 traditional Medicare patients, billed 25,218 HCPCS/CPT codes, and received $741,232 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,492 prescription claims across 175 beneficiaries totaling $841,772 in drug costs, led by Xolair (Omalizumab). DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $318,466 to $841,772. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	231	27,225	$564,695
2016	238	30,814	$702,423
2017	246	36,974	$920,741
2018	229	35,446	$990,868
2019	213	33,678	$907,512
2020	176	29,884	$832,483
2021	179	28,549	$857,690
2022	181	30,291	$911,132
2023	172	26,460	$810,512
2024	152	25,218	$741,232

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	174	1,359	$318,466
2016	159	1,438	$363,357
2017	170	1,477	$459,535
2018	173	1,535	$582,110
2019	165	1,642	$635,175
2020	152	1,552	$671,331
2021	150	1,417	$673,461
2022	147	1,401	$746,189
2023	158	1,432	$848,050
2024	175	1,492	$841,772

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	21	$214
2016	N/R	N/R	N/R
2017	N/R	28	$109
2018	N/R	11	$39
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$68
2023	N/R	11	$285
2024	N/R	11	$383

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	95	141	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	117	176	$49
95165	Professional service for preparation and provision of 1 or more antigens	22	830	$10
96372	Injection of drug or substance under skin or into muscle	27	473	$10
95117	Professional service for multiple injections of allergen	18	339	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	92	2,802	$355,450
Dupixent Syringe	Dupilumab	71	2,044	$285,498
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	2,010	$42,446
Advair Hfa	Fluticasone Propion/Salmeterol	35	1,890	$25,548
Symbicort	Budesonide/Formoterol Fumarate	51	2,244	$17,315

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	11	$383

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Rahul Kumar Vangala, M.D.?

Tedicare shows public-source Medicare data for Rahul Kumar Vangala, M.D. (NPI 1366499246), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rahul Kumar Vangala, M.D. have ACO affiliation data?

Rahul Kumar Vangala, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Rahul Kumar Vangala, M.D.?

Rahul Kumar Vangala, M.D. is linked to ALLERGY & ASTHMA CENTER OF MIDDLE GEORGIA, INC. (billing NPI 1831352574) in the available physician profile data.

Does Rahul Kumar Vangala, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.